Screening Recommendations for Colon Cancer
May 14th 2019Amber Draper, PharmD, BCOP, clinical pharmacist, Winship Cancer Institute in Georgia discusses current recommendations for colon cancer screening. This video was filmed at the 2019 Hematology/Oncology Pharmacy Association Annual Conference in Fort Worth, Texas.
Watch
Pifeltro and Delstrigo: New Options for HIV-1
May 14th 2019On August 30, 2018, the FDA approved Merck’s doravirine (Pifeltro) a non-nucleoside reverse transcriptase inhibitor and doravirine/lamivudine/tenofovir (Delstrigo) a once-daily single tablet regimen for the treatment of HIV-1 infection in appropriate patients.
Read More
Novel Intravenous Immune Globulin Product Relaunched with FDA Approval
May 14th 2019The novel intravenous immune globulin (IVIG) product is indicated for individuals with primary humoral immunodeficiency disease (PIDD), which includes X-linked and congenital agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiency.
Read More
Medication for Thrombocytopenia, Aplastic Anemia Recalled Due to Potential Peanut Contamination
May 13th 2019Novartis has issued a voluntary recall of 3 lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level, due to a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site.
Read More
Drug Receives FDA's Breakthrough Therapy Designation for Treating Individuals with Schizophrenia
May 11th 2019The designation is intended to expedite the development and review of drugs for serious or life-threatening conditions when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on one or more clinically significant endpoints.
Read More